For Belgium
Please report adverse events to the Belgian Centre for Pharmacovigilance for medicines for Human use of the Federal Agency for Medicines and Health Products adversedrugreactions@afmps.be or via the ‘yellow card’ available on www.fagg-afmps.be or to GlaxoSmithKline Pharmaceuticals s.a./n.v. 010/ 85 85 00.
For Luxembourg
Please report adverse events to the Centre Régional de Pharmacovigilance de Nancy crpv@chru-nancy.fr or to the Division de la Pharmacie et des Médicaments, Direction de la Santé à Luxembourg pharmacovigilance@ms.etat.lu or to GlaxoSmithKline Pharmaceuticals s.a./n.v. +32 10 85 85 00.
